mRNA

mRNA
#mRNA #Research and development #RNA sequencing #Takara Bio

New product could aid successful production of mRNA therapeutics

Takara Bio has launched PrimeCap T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development. PrimeCap T7 RNA Polymerase is a mutant T7 RNA polymerase that has been genetically engineered to maintain high-performance RNA synthesis activity while reducing dsRNA… Read More

#News

RNA strand
#Circio Holding #circular RNAs #Gene therapy #Genetic diseases #In vivo #mRNA

Data demonstrates superiority of circular RNA vs linear mRNA

In vivo proof-of-concept for Circio Holding’s differentiated circVec platform approach to gene therapy has been demonstrated in two posters at the American Society of Gene & Cell Therapy (ASGCT) 2024 annual meeting. The in vivo data showed statistically significant higher expression level and durability for circVec… Read More

#News

#Covid-19 vaccine #mRNA #mRNA-based vaccines #Oncology #RNA

The future outlook for mRNA therapies

Reece Armstrong explores the potential and future opportunities for mRNA-based therapies. Messenger RNA (mRNA) has come into focus within the drug discovery and development as an exciting tool to deliver genetic information. Whilst research into mRNA has been ongoing for decade, interest has sparked in recent years and research has… Read More

#Exclusive Content

Prostate cancer cells
#mRNA #Nutcracker Therapeutics #Oncology #Prostate cancer #T cell activation

mRNA prostate cancer drug successfully engaged CD3 T cells

Nutcracker Therapeutics’ prostate cancer mRNA drug candidate NTX-470 successfully engaged CD3 T cells, while retaining low bystander activity and reduced off-tumour binding, according to data presented at the 2024 AACR Annual Meeting. There are limited treatment options for the 10-20% of prostate cancer patients who develop… Read More

#Cancer Research #News

RNA strand
#Antisense Oligonucleotides (ASOs) #CAMP4 Therapeutics #CNS #Genetic diseases #mRNA #RNA #Turning Science into Business

Turning science into business: Amplifying mRNA by targeting regRNAs

DDW’s Diana Spencer speaks to Josh Mandel-Brehm, CEO of Massachusetts-based biotech CAMP4, to understand the role regulatory RNAs play in gene expression and how the founders overcame the challenge of launching a business based on brand new science. DS: CAMP4 leverages research from co-founder Richard Young on how regulatory RNA… Read More

#Business & Investment #Exclusive Content

#Antimicrobial resistance (AMR) #Cell and gene therapy #Europe #Immunology / Virology & Vaccines #Market reporting #mRNA #Plant-based

Read the Spring issue of DDW now

The Spring issue of Drug Discovery World (DDW) is out now. It looks at where we are in the fight against antimicrobial resistance, explores how structural biology is informing vaccine design, and offers advice on approaching dealmaking in biopharma. Read the digital version here. … Read More

#News

RNA
#Aarhus University #BioInnovation Institute #mRNA #RNA #Small RNA #Start-ups

smartRNA project joins BII Bio Studio programme

A project focused on developing a small RNA-based platform technology for treating monogenic diseases, smartRNA, has joined the BioInnovation Institute’s (BII) Bio Studio programme. The approach to achieve this involves delivering an engineered small artificial (smart)RNA into the cell, where it assembles with endogenous protein co-factors… Read More

#News #Start-up Zone

#3D chemistry #AI #Artificial intelligence (AI) #Biologics #Biotechnology #Cell and gene therapy #Contract development and manufacturing organisations #Covid-19 #Gene expression #Gene mutation #Interview #mRNA #Next generation sequencing #Oncology #PharmEnable #RNA sequencing #Single-cell RNA sequencing #Vaccines

Podcast: What trends will speed up the journey from clinic to bedside?

This is the latest episode of the free DDW narrated podcast, titled “What trends will speed up the journey from clinic to bedside?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Sitting down with… PharmEnable, Is single-cell… Read More

#News

Lipid nanoparticle siRNA antivirals
#etherna #Lipid based nanoparticle (LNP) #Lipids #mRNA

LNP formulations produce strong immune responses, data shows 

The strengths of etherna’s lipid based nanoparticle (LNP) platform have been showcased in a peer-reviewed paper in Advanced Functional Materials.   etherna’s Vice President, Technology & Innovation, Stefaan De Koker described the paper as a “landmark” for the company and its technology.  The RNA… Read More

#News

Respiratory system
#AI #Anima Biotech #Idiopathic pulmonary fibrosis #Lung disease #mRNA #Preclinical investigations

AI mRNA candidate shows early promise in lung fibrosis

A therapeutic candidate which operates through a novel mRNA biology mechanism of action could open new avenues for treating idiopathic pulmonary fibrosis (IPF) patients. Anima Biotech has identified a preclinical candidate, effectively disrupting the transformation of fibroblasts into fully differentiated myofibroblasts. By inhibiting myofibroblasts’… Read More

#News

RNA
#Business #FDA #mRNA #Oncology #Strand Therapeutics

Strand Therapeutics cuts workforce by 18%

Strand Therapeutics has announced an 18% cut to its workforce, just days after the US Food and Drug Administration (FDA) cleared its Investigational New Drug (IND) application to initiate a first-in-human trial of STX-001 for solid tumours. On LinkedIn the company said: “This week, Strand has made the difficult strategic… Read More

#Business & Investment #News #Trending News

Scientific technology
#AI / data analytics / healthtech / informatics #Clinical development #Data automation #Data management #Diagnostics #Drug discovery #Electronic Lab Notebooks (ELN) #FAIR Principles #Genomics #Immunology / Virology & Vaccines #Infectious diseases #Informatics #mRNA #Personalised medicine #Precision medicine #Predictive diagnostics #Public health

New podcast: Revolutionary technology for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Revolutionary technology for drug discovery and development” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: mRNA technology may hold the future for a cytomegalovirus vaccine; … Read More

#News

mRNA
#King's College London #Liver disease #Moderna #Mouse models #mRNA #Rare disease #University College London

Study reveals therapeutic potential of mRNA in rare diseases

Researchers have used messenger RNA (mRNA) to create an effective therapy for a rare liver disease in preclinical studies, demonstrating the technology’s potential therapeutic use in people. The team, led by University College London (UCL), King’s College London and Moderna scientists, found that mRNA could be… Read More

#Editor's Choice #News

Eye health ophthalmology
#Clinical trials #Diabetes #Exonate #Eye health #mRNA #Ophthalmology #Small molecules

Trial in diabetic macular oedema successfully completed  

Exonate, an mRNA therapy company focused on treatments for diabetic complications, has announced that its lead ophthalmology asset, EXN407, has achieved its prespecified endpoints in a Phase Ib/IIa study.   During the trial, EXN407 met all safety and pharmacokinetic parameters and displayed encouraging signals of biological activity. Exonate… Read More

#News

#AI / data analytics / healthtech / informatics #Big pharma #BioNTech #Biopharmaceuticals #Comirnaty #Covid-19 #Drug discovery #Healthcare #Moderna #mRNA #Pfizer

New podcast on drug discovery trends

This is the latest episode of the free DDW narrated podcast, “Drug discovery trends: From regulation to embracing AI”, which covers two articles written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: From the Editor: Law and order and… Read More

#News